4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-055069
Director sold 12,000 shares at an average $52.84 ($634,097)
- Director acquired 12,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
GRIFFIN MICHELLE RENEE · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-10-14 | Exercise or conversion : show line 1 in the form | +12,000 | $7.80 | $93,600 | 12,000 | D |
| 2020-10-14 | Sale : show line 2 in the form | −4,649 | $52.48 | $243,980 | 7,351 | D |
| 2020-10-14 | Sale : show line 3 in the form | −7,351 | $53.07 | $390,118 | 0 | D |
| Open-market sales · 12,000 sh · avg $52.84 · $634,097 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-10-14 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −12,000 | 113,000 | D |
Loading xslF345X03/doc4.xml…